Virosomes for antigen and DNA delivery

Advanced Drug Delivery Reviews

Volumn 57, Issue 3 SPEC. ISS., 2005, Pages 451-463

  Daemen, Toos ^a   De Mare, Arjan ^a   Bungener, Laura ^a   De Jonge, Jørgen ^a   Huckriede, Anke ^a   Wilschut, Jan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antigen; DNA; Virosomes

Indexed keywords

CELLS; CYTOLOGY; DISEASES; DNA; IMMUNIZATION; IMMUNOLOGY; PROTEINS; TUMORS; VACCINES; VIRUSES;

ANTIGEN-PRESENTING CELLS (APC); IMMUNITY; VACCINATION; VIROSOMES;

ANTIGENS;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CHLORAMPHENICOL ACETYLTRANSFERASE; CHOLESTEROL; DIOLEOYLDIMETHYLAMMONIUM; DIPHTHERIA TOXIN; DNA VACCINE; EPITOPE; HN PROTEIN; HYBRID PROTEIN; INFLUENZA VACCINE; LIPID; LIPOSOME; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NANOPARTICLE; OLIGONUCLEOTIDE; OVALBUMIN; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; PLASMID DNA; POVIDONE; RECOMBINANT ANTIGEN; SERYLISOLEUCYLISOLEUCYLASPARAGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIROSOME; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; ENCAPSULATION; GENE TARGETING; HELPER CELL; HUMAN; HUMORAL IMMUNITY; HYDROGEL; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; IMMUNOPROPHYLAXIS; IMMUNOSTIMULATION; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENDAI VIRUS; TECHNIQUE;

EID: 9244233812     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2004.09.005     Document Type: Review

References (55)

1. J.D. Almeida, D.C. Edwards, C.M. Brand, and T.D. Heath Formation of virosomes from influenza subunits and liposomes Lancet 2 1975 899 901
2. T. Stegmann, H.W. Morselt, F.P. Booy, J.F. van Breemen, G. Scherphof, and J. Wilschut Functional reconstitution of influenza virus envelopes EMBO J. 6 1987 2651 2659
3. R. Bron, J.M. Wahlberg, H. Garoff, and J. Wilschut Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein EMBO J. 12 1993 693 701
4. R. Bron, A. Ortiz, J. Dijkstra, T. Stegmann, and J. Wilschut Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes) Methods Enzymol. 220 1993 313 331
5. S. Gunther-Ausborn, P. Schoen, I. Bartoldus, J. Wilschut, and T. Stegmann Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity J. Virol. 74 2000 2714 2720
6. J.C. de Jong, G.F. Rimmelzwaan, R.A. Fouchier, and A.D. Osterhaus Influenza virus: a master of metamorphosis J. Infect. 40 2000 218 228
7. A.E. Smith, and A. Helenius How viruses enter animal cells Science 304 2004 237 242
8. K.S. Matlin, H. Reggio, A. Helenius, and K. Simons Infectious entry pathway of influenza virus in a canine kidney cell line J. Cell Biol. 91 1981 601 613
9. J.J. Skehel, and D.C. Wiley Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin Ann. Rev. Biochem. 69 2000 531 569
10. B. Morein, D. Barz, U. Koszinowski, and V. Schirrmacher Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome target cell fusion J. Exp. Med. 150 1979 1383 1398
11. A. Coulter, R. Harris, R. Davis, D. Drane, J. Cox, D. Ryan, P. Sutton, S. Rockman, and M. Pearse Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine Vaccine 21 2003 946 949
12. K. Nerome, Y. Yoshioka, M. Ishida, K. Okuma, T. Oka, T. Kataoka, A. Inoue, and A. Oya Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses Vaccine 8 1990 503 509
13. H. Iinuma, K. Nerome, Y. Yoshioka, and K. Okinaga Characteristics of cytotoxic T lymphocytes directed to influenza virus haemagglutinin elicited by immunization with muramyldipeptide-influenza liposome vaccine Scand. J. Immunol. 41 1995 1 10
14. R. Glück, R. Mischler, S. Brantschen, M. Just, B. Althaus, and S.J. Cryz Jr. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A J. Clin. Invest. 90 1992 2491 2495
15. R. Zurbriggen Immunostimulating reconstituted influenza virosomes Vaccine 21 2003 921 924
16. S. Bagai, and D.P. Sarkar Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells Biochim. Biophys. Acta 1152 1993 15 25
17. S. Bagai, and D.P. Sarkar Effect of substitution of hemagglutinin- neuraminidase with influenza hemagglutinin on Sendai virus F protein mediated membrane fusion FEBS Lett. 353 1994 332 336
18. A. Orellana, D. Mottershead, I. van der Linden, K. Keinanen, and C. Okerblom Mimicking rubella virus particles by using recombinant envelope glycoproteins and liposomes J. Biotechnol. 75 1999 209 219
19. D. Loh, A.H. Ross, A.H. Hale, D. Baltimore, and H.N. Eisen Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes J. Exp. Med. 150 1979 1067 1074
20. J. Shoji, Y. Tanihara, T. Uchiyama, and A. Kawai Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells Microbiol. Immunol. 48 2004 163 174
21. S. Grimaldi, A. Giuliani, A. Giuliani, L. Ferroni, A. Lisi, N. Santoro, and D. Pozzi Engineered liposomes and virosomes for delivery of macromolecules Res. Virol. 146 1995 289 293
22. B. Cornet, M. Vandenbranden, J. Cogniaux, L. Giurgea, D. Dekegel, and J.M. Ruysschaert Virosomes reconstituted from human immunodeficiency virus proteins and lipids Biochem. Biophys. Res. Commun. 167 1990 222 231
23. A. Helenius, E. Fries, and J. Kartenbeck Reconstitution of Semliki Forest virus membrane J. Cell Biol. 75 1977 866 880
24. J. Schneider, H. Falk, and G. Hunsmann Virosomes constructed from lipid and purified Friend leukaemia virus glycoprotein J. Gen. Virol. 64 1983 559 565
25. D.C. Johnson, M. Wittels, and P.G. Spear Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion J. Virol. 52 1984 238 247
26. D.R. Kapczynski, and T.M. Tumpey Development of a virosome vaccine for Newcastle disease virus Avian Dis. 47 2003 578 587
27. A. Huckriede, L. Bungener, T. Daemen, and J. Wilschut Influenza virosomes in vaccine development Methods Enzymol. 373 2003 74 91
28. A. Arkema, A. Huckriede, P. Schoen, J. Wilschut, and T. Daemen Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes Vaccine 18 2000 1327 1333
29. L. Bungener, K. Serre, L. Bijl, L. Leserman, J. Wilschut, T. Daemen, and P. Machy Virosome-mediated delivery of protein antigens to dendritic cells Vaccine 20 2002 2287 2295
30. P. Schoen, A. Chonn, P.R. Cullis, J. Wilschut, and P. Scherrer Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles Gene Ther. 6 1999 823 832
31. E.R. Waelti, and R. Glück Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes) Int. J. Cancer 77 1998 728 733
32. P. Correale, M.G. Cusi, M. Sabatino, L. Micheli, D. Pozzessere, C. Nencini, P.E. Valensin, R. Petrioli, G. Giorgi, R. Zurbriggen, R. Glück, and G. Francini Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes Eur. J. Cancer 37 2001 2097 2103
33. K. Ramani, R.S. Bora, M. Kumar, S.K. Tyagi, and D.P. Sarkar Novel gene delivery to liver cells using engineered virosomes FEBS Lett. 404 1997 164 168
34. H.S. Kim, and Y.S. Park Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes Cancer Gene Ther. 9 2002 173 177
35. H.S. Kim, and Y.S. Park Effect of lipid compositions on gene transfer into 293 cells using Senda F/HN-virosomes J. Biochem. Mol. Biol. 35 2002 459 464
36. E. Ponimaskin, K.K. Bareesel, K. Markgraf, R. Reszka, K. Lehmann, H.R. Gelderblom, M. Gawaz, and M.E. Schmidt Sendai virosomes revisited: reconstitution with exogenous lipids leads to potent vehicles for gene transfer Virology 269 2000 391 403
37. Y. Saeki, N. Matsumoto, Y. Nakano, M. Mori, K. Awai, and Y. Kaneda Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer Hum. Gene Ther. 8 1997 2133 2141
38. V.J. Dzau, M.J. Mann, R. Morishita, and Y. Kaneda Fusigenic viral liposome for gene therapy in cardiovascular diseases Proc. Natl. Acad. Sci. 93 1996 11421 11425
39. P.A. Bullough, F.M. Hughson, J.J. Skehel, and D.C. Wiley Structure of influenza haemagglutinin at the pH of membrane fusion Nature 371 1994 37 43
40. K. Ramani, Q. Hassan, B. Venkaiah, S.E. Hasnain, and D.P. Sarkar Site-specific gene delivery in vivo through engineered Sendai viral envelopes Proc. Natl. Acad. Sci. U. S. A. 95 1998 11886 11890
41. A. Huckriede, L. Bungener, W. ter Veer, M. Holtrop, T. Daemen, A.M. Palache, and J. Wilschut Influenza virosomes: combining optimal presentation of hemagglutinin immunopotentiating activity Vaccine 21 2003 925 931
42. R. Glück, R. Mischler, B. Finkel, J.U. Que, B. Scarpa, and S.J. Cryz Immunogenicity of new virosome influenza vaccine in elderly people Lancet 344 1994 160 163
43. S. Ando, H. Tsuge, and T. Mayumi Preparation of influenza virosome vaccine with muramyldipeptide derivative B30-MDP J. Microencapsul 14 1997 79 90
44. A. Boudreault, and L. Thibodeau Mouse response to influenza immunosomes Vaccine 3 1985 231 234
45. N. El Guink, R.M. Kris, G. Goodman-Snitkoff, P.A. Small Jr., and R.J. Mannino Intranasal immunization with proteoliposomes protects against influenza Vaccine 7 1989 147 151
46. R. Bron, A. Ortiz, and J. Wilschut Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes) Biochemistry 33 1994 9110 9117
47. M. Kumar, and D.P. Sarkar F protein induced fusion of Sendai viral envelopes with mouse teratocarcinoma cells through Le(x)-Le(x) interaction FEBS Lett. 391 1996 17 20
48. S.S. Jana, D.J. Bharali, P. Mani, A. Maitra, C.M. Gupta, and D.P. Sarkar Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes FEBS Lett. 515 2002 184 188
49. T. Nakanishi, A. Hayashi, J. Kunisawa, Y. Tsutsumi, K. Tanaka, Y. Yashiro-Ohtani, M. Nakanishi, H. Fujiwara, T. Hamaoka, and T. Mayumi Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway Eur. J. Immunol. 30 2000 1740 1747
50. O.L. Wijburg, G.P. van den Dobbelsteen, J. Vadolas, A. Sanders, R.A. Strugnell, and N. van Rooijen The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens Eur. J. Immunol. 28 1998 479 487
51. R. Schumacher, M. Adamina, R. Zurbriggen, M. Bolli, E. Padovan, P. Zajac, M. Heberer, and G.C. Spagnoli Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation Vaccine 22 2004 714 723
52. N. Duzgunes, C.T. De Ilarduya, S. Simoes, R.I. Zhdanov, K. Konopka, and M.C. Pedroso de Lima Cationic liposomes for gene delivery: novel cationic lipids and enhancement by proteins and peptides Curr. Med. Chem. 10 2003 1213 1220
53. M.G. Cusi, C. Terrosi, G.G. Savellini, G. di Genova, R. Zurbriggen, and P. Correale Efficient delivery of DNA to dendritic cells mediated by influenza virosomes Vaccine 22 2004 735 739
54. M.G. Cusi, R. Zurbriggen, M. Valassina, S. Bianchi, P Durrer, P.E. Valensin, M. Donati, and R. Guck Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity Virology 277 2000 111 118
55. A. Scardino, P. Correale, H. Firat, M. Pellegrini, K. Kosmatopoulos, P. Opolon, P. Alves, R. Zurbriggen, F.A. Gluck, G. Lemonnier, G. Francini, and M.G. Cusi In vitro study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse Br. J. Cancer 89 2003 199 205